Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells
Cisplatin (CDDP) is one of the main chemotherapeutic drugs that is widely used in many cancers. However, CDDP resistance is a frequent therapeutic challenge that reduces prognosis in cancer patients. Since, CDDP has noticeable side effects in normal tissues and organs, it is necessary to assess the...
Saved in:
Main Authors: | Amirhosein Maharati, Yasamin Rajabloo, Meysam Moghbeli |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024175147 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AKT/mTOR信号通路在喉癌组织中的表达及意义
Published: (2009-01-01) -
Reactivation of mTOR signaling slows neurodegeneration in a lysosomal sphingolipid storage disease
by: Hongling Zhu, et al.
Published: (2025-01-01) -
Apigenin suppresses osteoarthritis progression by inhibiting pyroptosis via SIRT1/mTOR pathway-mediated mitophagy
by: Jiahao Ying, et al.
Published: (2025-01-01) -
Porphyra haitanensis polysaccharide (PH) attenuates cell hyperplasia via remodeling the cross-talk between Hippo/YAP and mTOR pathways
by: Chong Wang, et al.
Published: (2023-03-01) -
ACOX1 activates autophagy via the ROS/mTOR pathway to suppress proliferation and migration of colorectal cancer
by: Bo Shi, et al.
Published: (2025-01-01)